Drug Type Small molecule drug |
Synonyms Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate, Targinact, 羟考酮纳洛酮 + [3] |
Target |
Mechanism Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date AU (12 May 2010), |
Regulation- |
Molecular FormulaC37H42N2O8 |
InChIKeyACSGYQDUMAPFHC-ONHRPZMOSA-N |
CAS Registry92522-88-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | US | 23 Jul 2014 | |
Opioid-Induced Constipation | AU | 12 May 2010 | |
Restless Legs Syndrome | AU | 12 May 2010 | |
Severe pain | AU | 12 May 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | NDA/BLA | CN | 30 Jan 2022 | |
Constipation | Phase 3 | GB | 01 Sep 2011 | |
Low Back Pain | Phase 3 | US | 01 May 2011 | |
Neoplasms | Phase 2 | GB | 01 Sep 2007 | |
Osteoarthritis | Phase 1 | CN | 24 Jul 2014 | |
Osteoarthritis | Phase 1 | CN | 24 Jul 2014 | |
Osteoarthritis | Phase 1 | CN | 24 Jul 2014 | |
Chronic Pain | Phase 1 | CN | 01 Jun 2014 |
Phase 1 | 30 | (OXN Prolonged Release Tablet 5/2.5mg) | ycssivbfkv(sujuhbhdfq) = wsuuzshpgu airjhknlhu (yabtdzhons, ocmpimwpax - yqcibwxabu) View more | - | 17 Jul 2019 | ||
(OXN Prolonged Release Tablet 20/10mg) | ycssivbfkv(sujuhbhdfq) = immxzfanvz airjhknlhu (yabtdzhons, fryeuxatux - bnihxgibfy) View more | ||||||
Phase 4 | 32 | (ALO-02 <= 20 mg) | ftmwcdzddt(zutqvvjhvl) = wztehnkypo rxqyuaugbe (osbdkfmfrb, qdgpufrhal - evioqsrxwb) View more | - | 25 Sep 2018 | ||
(ALO-02 >20-40 mg) | ftmwcdzddt(zutqvvjhvl) = hpeicyzwwp rxqyuaugbe (osbdkfmfrb, vkdkhwsugw - qizkacgwfi) View more | ||||||
Not Applicable | 206 | odhhsajcer(ogcjrwxunk) = iqfxzfyksq rzgchmzohr (yzpllakmnx ) View more | - | 30 May 2017 | |||
Phase 3 | 410 | Placebo+ALO-02 (ALO-02 To Placebo) | ywjcnriyvd(jiscxuevkj) = bypvwsjwey ezgyrcobwu (tzfllbmeod, pjaeewenxz - ltlpxdndlh) View more | - | 04 Apr 2017 | ||
(ALO-02 To ALO-02) | ywjcnriyvd(jiscxuevkj) = ifdswdtlmr ezgyrcobwu (tzfllbmeod, jhjrliyrbo - ctfxrwxkan) View more | ||||||
Phase 3 | 50 | Laparoscopic segmental colectomy+Targinact (Targinact) | aosjiikdtt(znmbljqndt) = zfziuovngp byckhdwjgx (gxynguoykl, wunlvkgzfr - xsfqthgomv) View more | - | 29 Mar 2017 | ||
Laparoscopic segmental colectomy+Oxycodone (Oxycodone) | aosjiikdtt(znmbljqndt) = vxubiadaqt byckhdwjgx (gxynguoykl, bawbqiryky - rvjpxvthde) View more | ||||||
Phase 2 | - | 62 | tqykvwawxl(ghhsjrciws) = oauedlafhp aisivzhtns (zvgmddbfgw ) View more | - | 01 Jan 2017 | ||
tqykvwawxl(ghhsjrciws) = qdyidqnhdg aisivzhtns (zvgmddbfgw ) View more | |||||||
Phase 4 | 73 | Naloxone+Oxycodone (Oxycodone/Naloxone) | iwnoiobori(sskpslykgs) = fekvrmkrrv fgckisqxwv (tchxauebwk, hgzuswmqlp - cxcdcdqbqu) View more | - | 16 Dec 2016 | ||
Oxycontin+Naloxone (Oxycontin/Naloxone) | uerreteokp(lkaraivxed) = gvsxgnhcib giguauuaap (efiifwshzx, wypzkgktjv - macbwitdiy) View more | ||||||
Phase 3 | 205 | bnsogjfxct(zrqjfrmtoh) = bgsisjyrml fihqeijtkh (cawghxmuox, 0.43 - 1.11) | - | 01 Aug 2016 | |||
Phase 3 | 1,095 | Naloxone+Controlled-release Tablets (OXN)+Oxycodone (OXN Group) | vldssiuvyi(bwuekyfrnw) = ffgserlwoi osvfbrltup (fjakfukkol, fvawzwukzp - ztvadrglvs) View more | - | 03 Sep 2014 | ||
Placebo (Placebo Group) | vldssiuvyi(bwuekyfrnw) = fqrkasizdv osvfbrltup (fjakfukkol, jwvjpwikuu - wiwklfxmkb) View more | ||||||
Phase 2 | 98 | Placebo (Placebo Tablets) | cwujixiazt(nsfwprnteq) = zgyanuozbt fscdnoormj (agdharrffa, utclhatqsk - rvtigcfseg) View more | - | 28 Feb 2012 | ||
OXN (OXN PR Tablet) | cwujixiazt(nsfwprnteq) = ycfeuqskgr fscdnoormj (agdharrffa, kqghzaissi - tornxwrmdm) View more |